Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal

Clinical trial NCT03887429 · COMPLETED

Trial details

NCT number: NCT03887429
Sponsor: Promentis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Impulse Control Disorders

Start date: 2019-03-04
Primary completion: 2019-07-02
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.